Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Syndecan 4 ELISA Kit (AC3598)
Cat.#: ASET-2187
Specifications
Description Mouse Syndecan 4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Syndecan 4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.56 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15-240 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1666 Porcine Ghrelin ELISA Kit (AC3077) Quantitative inquiry ASET-1433 Sheep Ghrelin ELISA Kit (AC2844) Quantitative inquiry ASET-2261 Mouse Cathepsin B ELISA Kit (AC3672) Quantitative inquiry ASET-2426 Human GABRD ELISA Kit (AC3837) Quantitative inquiry ASET-2530 Rat Antidiuretic Hormone ELISA Kit (AC3941) Quantitative inquiry ASET-1592 Human Calnexin ELISA Kit (AC3003) Quantitative inquiry ASET-2479 Rat ASRGL1 ELISA Kit (AC3890) Quantitative inquiry ASET-1776 Human Synapsin I ELISA Kit (AC3187) Quantitative inquiry ASET-1564 Porcine FGF19 ELISA Kit (AC2975) Quantitative inquiry ASET-1313 Mouse beta III Tubulin ELISA Kit (AC2724) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket